Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer YERXA BENJAMIN R
Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George
Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer YERXA BENJAMIN R
D: Filing D
4: Statement of changes in beneficial ownership of securities-Officer Magrath George
SC 13D: Statement of acquisition of beneficial ownership by individuals-Foundation Fighting Blindness Retinal Degeneration Fund(8.16%),Foundation Fighting Blindness, Inc.(8.16%)
3: Initial statement of beneficial ownership of securities-Director Foundation Fighting Blindness Retinal Degeneration Fund
4: Statement of changes in beneficial ownership of securities-Director Graves Adrienne L
4: Statement of changes in beneficial ownership of securities-Director Bennett Jean
3: Initial statement of beneficial ownership of securities-Officer YERXA BENJAMIN R
3: Initial statement of beneficial ownership of securities-Director Graves Adrienne L
3: Initial statement of beneficial ownership of securities-Director Bennett Jean
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Pepose Jay
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Cam
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director MANUSO JAMES S J
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Benton Susan
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Ainsworth Sean
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jayagopal Ashwath
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George
No Data
No Data